Placebo mechanisms across different conditions: from the clinical setting to physical performance
- 27 June 2011
- journal article
- review article
- Published by The Royal Society in Philosophical Transactions Of The Royal Society B-Biological Sciences
- Vol. 366 (1572), 1790-1798
- https://doi.org/10.1098/rstb.2010.0381
Abstract
Although the great increase in interest in the placebo phenomenon was spurred by the clinical implications of its use, the progressive elucidation of the neurobiological and pharmacological mechanisms underlying the placebo effect also helps cast new light on the relationship between mind (and brain) and body, a topic of foremost philosophical importance but also a major medical issue in light of the complex interactions between the brain on the one hand and body functions on the other. While the concept of placebo can be a general one, with a broad definition generally applicable to many different contexts, the description of the cerebral processes called into action in specific situations can vary widely. In this paper, examples will be given where physiological or pathological conditions are altered following the administration of an inert substance or verbal instructions tailored to induce expectation of a change, and explanations will be offered with details on neurotransmitter changes and neural pathways activated. As an instance of how placebo effects can extend beyond the clinical setting, data in the physical performance domain and implications for sport competitions will also be presented and discussed.Keywords
This publication has 85 references indexed in Scilit:
- Introduction to placebo effects in medicine: mechanisms and clinical implicationsPhilosophical Transactions Of The Royal Society B-Biological Sciences, 2011
- Behavioural conditioning as the mediator of placebo responses in the immune systemPhilosophical Transactions Of The Royal Society B-Biological Sciences, 2011
- How Placebos Change the Patient's BrainNeuropsychopharmacology, 2010
- Electrophysiological properties of thalamic, subthalamic and nigral neurons during the anti‐parkinsonian placebo responseThe Journal of Physiology, 2009
- Neurobiological Mechanisms of Placebo ResponsesAnnals of the New York Academy of Sciences, 2009
- New Insights into the Placebo and Nocebo ResponsesNeuron, 2008
- Placebo effects on human μ-opioid activity during painProceedings of the National Academy of Sciences of the United States of America, 2007
- Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleusNature Neuroscience, 2004
- Placebo and Opioid Analgesia-- Imaging a Shared Neuronal NetworkScience, 2002
- THE MECHANISM OF PLACEBO ANALGESIAThe Lancet, 1978